Table 2.
Delivery | Genetic modification | Species | Reference(s) | Application |
---|---|---|---|---|
Lentiviruses | Gain of function | Human | Zaldumbide et al. (2013) | Misexpression of immune-evasion proteins |
Arda et al. (2016) Peiris et al. (2018) Bevacqua et al. (2021a) |
Misexpression of transcription factors Misexpression of transcription factors Misexpression of transcription factors |
|||
Rats | Caton et al. (2003) | Misexpression of various connexins | ||
Lentiviruses | Loss of function (shRNAs) | Human | Peiris et al. (2018) | Silencing of transcription factor |
Harata et al. (2018) | Silencing of glucokinase | |||
Liu et al. (2019) | Technical report | |||
Liu et al. (2020) | Silencing of adipose triglyceride lipase | |||
Bevacqua et al. (2021a) | Silencing of transcription factor | |||
Lentiviruses | Knockout (indels/deletions) | Human | Bevacqua et al. (2021b) | CRISPR/Cas9 knockout of transcription factors and noncoding regulatory DNA |
Lentiviruses | Endogenous gene activation | Human | Bevacqua et al. (2021b) | CRISPR-A of a transcription factor and enhancer |
Adenoviruses | Gain of function | Human | Walker et al. (2020) | Misexpression of biosensor (GCAMP), study of cell-cell interactions |
Furuyama et al. (2019) | Reprogramming of α-cells via ectopic expression of β-cell transcription factors | |||
Mice | van Krieken et al. (2019) | Amplification of the V1b receptor signaling | ||
Herpes simplex virus | Gain of function | Human | Rabinovitch et al. (1999) | Misexpression of antiapoptotic gene (bcl-2) |